D.A. Davidson & Co’s NanoViricides NNVC Stock Holding History

D.A. Davidson & Co’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-94	Closed	-$2K	–	1685
2017 Q2	$2K	Hold	94	–	–	﹤0.01%	2295
2017 Q1	$2K	Hold	94	–	–	﹤0.01%	2266
2016 Q4	$2K	Hold	94	–	–	﹤0.01%	2361
2016 Q3	$3K	Hold	94	–	–	﹤0.01%	2259
2016 Q2	$3K	Hold	94	–	–	﹤0.01%	2212
2016 Q1	$4K	Hold	94	–	–	﹤0.01%	2081
2015 Q4	$2K	Hold	94	–	–	﹤0.01%	2139
2015 Q3	$2K	Hold	94	–	–	﹤0.01%	2103
2015 Q2	$3K	Hold	94	–	–	﹤0.01%	2077
2015 Q1	$4K	Hold	94	–	–	﹤0.01%	1943
2014 Q4	$5K	Hold	94	–	–	﹤0.01%	1928
2014 Q3	$5K	Hold	94	–	–	﹤0.01%	1932
2014 Q2	$7K	Hold	94	–	–	﹤0.01%	1867
2014 Q1	$6K	Buy	94 +8	+9%	+$684	﹤0.01%	1898
2013 Q4	$8K	Buy	+86	New	+$8.85K	﹤0.01%	1780

Other funds holding NNVC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PTB

Pioneer Trust Bank Salem, Oregon $441M AUM 21.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

SCA

STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.57B AUM 26.96% 1-Year Est. Return

D.A. Davidson & Co's NNVC Position: Q3 2017 in Review

D.A. Davidson & Co sold out of NanoViricides (NNVC) in Q3 2017, closing a stake of 94 shares — an estimated $2K sold.

D.A. Davidson & Co first reported a position in NNVC in Q4 2013 and held it in 15 quarters. The position peaked at $8K in Q4 2013. 45 funds tracked by Wall St. Rank hold NNVC as of Q3 2017.

D.A. Davidson & Co reported no remaining NanoViricides position as of Q3 2017 after selling out during the quarter.
D.A. Davidson & Co sold 94 NanoViricides shares in Q3 2017, an estimated $2K.
D.A. Davidson & Co first reported a position in NanoViricides in Q4 2013 and held it in 15 quarters.
D.A. Davidson & Co's NanoViricides position peaked at $8K in Q4 2013.
45 funds tracked by Wall St. Rank held NanoViricides as of Q3 2017.

Based on D.A. Davidson & Co's 13F filing for Q3 2017, filed 8 Nov 2017.